- Home
- LFCR vs SABA Comparison
LFCR vs SABA Comparison
Compare LFCR & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.12
Company Overview
Basic Information| Metric | LFCR | SABA |
|---|---|---|
| Founded | 1986 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.9M | 221.3M |
| IPO Year | 1996 | 1994 |
Fundamental Metrics
Financial Performance| Metric | LFCR | SABA |
|---|---|---|
| Price | $4.12 | $8.13 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 120.1K | 50.8K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.91% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $557,559,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $3.63 | $7.80 |
| 52 Week High | $8.98 | $9.20 |
Technical Indicators
Market Signals| Indicator | LFCR | SABA |
|---|---|---|
| Relative Strength Index (RSI) | 36.36 | 39.72 |
| Support Level | $3.63 | $7.97 |
| Resistance Level | $4.88 | $8.24 |
| Average True Range (ATR) | 0.23 | 0.07 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 12.05 | 27.08 |
Price Performance
Historical Comparison LFCR
SABA
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.